Not finding it? Sign in to also search OpenAlex live.
-
Discontinuation of anti‑programmed cell death protein 1 immune checkpoint inhibition after complete remission in head and neck squamous cell carcinoma: A case report and literature review
Manuel Stöth, Till Jasper Meyer, Thomas Eckhard Gehrke, Rudolf Hagen, Matthias Scheich, Stephan Hackenberg, +1 more
6citations -
Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation2024 American Journal of Hematology article Medicine Hematopoietic Stem Cell Transplantation Open access
Frédéric Baron, Myriam Labopin, Jurjen Versluis, Jan Vydra, Peter A. von dem Borne, Emma Nicholson, +12 more
3citations -
Tacrolimus versus cyclosporine a combined with post-transplantation cyclophosphamide for AML In first complete remission: a study from the acute leukemia working party (EBMT)2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Gesine Bug, Myriam Labopin, Alexander Kulagin, Didier Blaise, Anna Maria Raiola, Jan Vydra, +13 more
0citations -
Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working Party2020 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Éolia Brissot, Myriam Labopin, Domenico Russo, Sonja Martin, Christoph Schmid, Bertram Glaß, +8 more
20citations -
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party2025 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Nour M. Moukalled, Allain-Thibeault Le Sourd Ferhat, Ali A. Bazarbachi, Didier Blaise, Annoek E. C. Broers, Cristina Castilla‐Llorente, +15 more
2citations -
Allogeneic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia with Myelodysplasia-Related Features in First Complete Remission As per the International Consensus Classification (ICC) 2022: A Study from the ALWP of the EBMT2024 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Arnon Nagler, Myriam Labopin, Jurjen Versluis, Jaime Sanz, Tobias Gedde‐Dahl, David Burns, +11 more
1citations -
Additional file 1 of Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT
Yishan Ye, Jacques‐Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub‐Agha, Matthias Stelljes, +20 more
0citations -
Additional file 1 of Comparison of haploidentical, matched sibling and matched unrelated donor allo-HCT in adult patients with AML in complete remission with measurable residual disease: a study from the Global committee and the ALWP of the EBMT
Yishan Ye, Jacques‐Emmanuel Galimard, Myriam Labopin, Francis Ayuk, Ibrahim Yakoub‐Agha, Matthias Stelljes, +20 more
0citations -
Trends in Allogeneic Transplantation for Favorable Risk Acute Myeloid Leukemia in First Complete Remission: A Longitudinal Study of > 15 Years from the ALWP/EBMT2024 Transplantation and Cellular Therapy article Medicine Acute Myeloid Leukemia Research Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
0citations -
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial
Matthias Stelljes, Jan Moritz Middeke, Gesine Bug, Eva‐Maria Wagner‐Drouet, Lutz Peter Müller, Christoph Schmid, +62 more
53citations -
Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial
Christoph Röllig, Björn Steffen, Nael Alakel, Regina Herbst, Richard Noppeney, Maher Hanoun, +32 more
5citations -
Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT2024 Bone Marrow Transplantation article Medicine Hematopoietic Stem Cell Transplantation Open access
Arnon Nagler, Myriam Labopin, Urpu Salmenniemi, Depei Wu, Didier Blaise, Alessandro Rambaldi, +15 more
3citations -
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction2020 Annals of the Rheumatic Diseases article Medicine Spondyloarthritis Studies and Treatments Open access
Robert Landewé, Désirée M F M van der Heijde, Maxime Dougados, Xenofon Baraliakos, Filip E Van den Bosch, Karl Gaffney, +6 more
73citations -
Stable remission of depression after antidepressant treatment: prevalence and related sociodemographic and clinical characteristics in a longitudinal, real-world cohort
Mariska Bot, Suzanne A. Ligthart, Huibert Burger, Nina H. Grootendorst–van Mil, Ingrid A. Arnold, Sjoerd M. van Belkum, +9 more
1citations -
Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials2026 SKIN The Journal of Cutaneous Medicine article Immunology and Microbiology Psoriasis: Treatment and Pathogenesis Open access
Joseph Frank Merola, April Armstrong, Deepak Balak, Jason Ezra Hawkes, Leon Kircik, Fiona E. Lovegrove, +4 more
0citations -
The trajectory of clinical responses in patients with early rheumatoid arthritis who achieve sustained remission in response to abatacept: subanalysis of AVERT-2, a randomized phase IIIb study2023 Arthritis Research & Therapy article Medicine Rheumatoid Arthritis Research and Therapies Open access
Paul E. Emery, Yoshiya Tanaka, Vivian P. Bykerk, Clifton O. Bingham, Gustavo Citera, Kuan‐Hsiang Gary Huang, +6 more
4citations -
Proposed Strategies to Increase the Likelihood of Achieving Remission in CRSwNP by EUFOREA2026 The Journal of Allergy and Clinical Immunology In Practice article Medicine Sinusitis and nasal conditions Open access
Peter William Hellings, Stella S. Lee, Eugenio De Corso, Saad A. Alsaleh, N. H. Alotaibi, Vibeke Backer, +20 more
0citations -
Three‐Year Results of Tapering Tumor Necrosis Factor Inhibitor to Withdrawal Compared to Stable Tumor Necrosis Factor Inhibitor Among Patients With Rheumatoid Arthritis in Sustained Remission: A Multicenter Randomized Trial2025 Arthritis & Rheumatology article Medicine Rheumatoid Arthritis Research and Therapies Open access
Kaja E Kjørholt, Nina Paulshus Sundlisæter, Anna‐Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Stavland Lexberg, +15 more
6citations